Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
842.71
940.94
1,074.47
956.00
739.43
761.37
681.14
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
842.71
940.94
1,074.47
956.00
739.43
761.37
681.14
Raw Material Cost
239.49
227.48
255.79
208.92
172.18
167.76
149.45
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
18.86
12.93
11.90
18.27
7.06
6.94
4.10
Selling and Distribution Expenses
505.22
578.58
671.11
602.39
467.71
488.29
432.94
Other Expenses
1.96
2.36
0.88
0.10
0.62
1.41
2.77
Total Expenditure (Excl Depreciation)
783.15
842.60
947.57
830.63
653.14
677.08
614.23
Operating Profit (PBDIT) excl Other Income
59.6
98.3
126.89999999999999
125.39999999999999
86.30000000000001
84.3
66.9
Other Income
20.67
5.93
7.01
7.93
4.89
6.14
20.03
Operating Profit (PBDIT)
118.62
130.87
160.11
160.30
112.24
107.84
99.64
Interest
18.86
12.93
11.90
18.27
7.06
6.94
4.10
Exceptional Items
-0.11
-0.80
-0.51
0.00
0.00
0.00
-0.33
Gross Profit (PBDT)
603.22
713.46
818.68
747.08
567.24
593.61
531.69
Depreciation
38.89
24.72
26.36
25.38
21.23
17.85
13.85
Profit Before Tax
60.76
92.42
121.34
116.65
83.94
83.04
81.37
Tax
8.43
11.55
9.83
16.04
9.84
12.18
10.97
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
52.32
80.87
111.52
100.61
74.10
71.42
70.98
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
52.32
80.87
111.52
100.61
74.10
71.42
70.98
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
-0.56
-0.58
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
52.32
80.87
111.52
100.61
74.10
70.87
70.40
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,194.72
1,113.33
1,121.93
890.44
828.30
707.44
658.72
Earnings per share (EPS)
0.24
0.33
0.46
0.41
0.31
0.32
0.31
Diluted Earnings per share
0.24
0.33
0.46
0.41
0.31
0.32
0.31
Operating Profit Margin (Excl OI)
7.01%
10.65%
11.8%
13.28%
11.65%
11.01%
9.65%
Gross Profit Margin
11.82%
12.45%
13.75%
14.86%
14.22%
13.25%
13.98%
PAT Margin
6.21%
8.59%
10.38%
10.52%
10.02%
9.38%
10.42%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is -10.44% vs -12.43% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is -35.35% vs -27.44% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is -21.54% vs -18.42% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 46.51% vs 8.40% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has fallen from Dec 2023
Compare Annual Results Of Guiyang Xintian Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
842.71
0
842.71
Other Operating Income
0.00
0.00
0.00
Total Operating income
842.71
0
842.71
Raw Material Cost
239.49
0
239.49
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
18.86
0
18.86
Selling and Distribution Expenses
505.22
0
505.22
Other Expenses
1.96
0.00
1.96
Total Expenditure (Excl Depreciation)
783.15
0
783.15
Operating Profit (PBDIT) excl Other Income
59.56
0.00
59.56
Other Income
20.67
0
20.67
Operating Profit (PBDIT)
118.62
0
118.62
Interest
18.86
0
18.86
Exceptional Items
-0.11
0
-0.11
Gross Profit (PBDT)
603.22
0
603.22
Depreciation
38.89
0
38.89
Profit Before Tax
60.76
0
60.76
Tax
8.43
0
8.43
Provisions and contingencies
0
0
0.00
Profit After Tax
52.32
0
52.32
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
52.32
0
52.32
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
52.32
0
52.32
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,194.72
0
1,194.72
Earnings per share (EPS)
0.24
0
0.24
Diluted Earnings per share
0.24
0
0.24
Operating Profit Margin (Excl OI)
7.01%
0%
0.00
7.01%
Gross Profit Margin
11.82%
0%
0.00
11.82%
PAT Margin
6.21%
0%
0.00
6.21%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 84.27 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -10.44% vs -12.43% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 5.23 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -35.35% vs -27.44% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 9.80 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -21.54% vs -18.42% in Dec 2023
Annual - Interest
Interest 1.89 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 46.51% vs 8.40% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.01%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has fallen from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
